Eiger BioPharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$12.6M, a 48.5% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$71.8M, a 22.6% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$71.8M, a 22.6% increase from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$92.7M, a 20.5% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$76.9M, a 23.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$71.8M -$12.6M +$11.9M +48.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-08
Q3 2023 -$83.6M -$16.9M +$9.44M +35.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$93.1M -$20M +$99K +0.49% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$93.2M -$22.3M -$443K -2.03% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$92.7M -$24.5M -$3.56M -17% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-08
Q3 2022 -$89.2M -$26.4M -$4.52M -20.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$84.7M -$20.1M -$1.72M -9.36% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$82.9M -$21.8M -$6.01M -38% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$76.9M -$20.9M -$2.95M -16.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 -$74M -$21.9M -$7.01M -47.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$67M -$18.4M -$3.73M -25.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$63.2M -$15.8M -$1.09M -7.41% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$62.1M -$18M -$1.45M -8.79% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-17
Q3 2020 -$60.7M -$14.8M +$3.47M +19% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$64.2M -$14.6M +$2.53M +14.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$66.7M -$14.7M +$2.2M +13% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$68.9M -$16.5M -$419K -2.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 -$68.5M -$18.3M -$1.47M -8.71% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$67M -$17.2M -$7.55M -78.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$59.5M -$16.9M -$8.42M -99% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$51M -$16.1M -$5.51M -52% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-09
Q3 2018 -$45.5M -$16.8M -$7.97M -89.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$37.6M -$9.61M +$1.47M +13.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$39M -$8.51M +$2.48M +22.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$41.5M -$10.6M +$2.32M +18% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-13
Q3 2017 -$43.8M -$8.87M +$2.46M +21.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$46.3M -$11.1M +$2.12M +16.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$48.4M -$11M -$2.31M -26.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$46.1M -$12.9M -$6.2M -92.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 -$39.9M -$11.3M -$8.46M -295% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$31.5M -$13.2M -$10.6M -411% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$20.8M -$8.68M -$7.87M -979% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$13M -$6.71M -$27.3M -133% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 $14.3M -$2.87M +$5.26M +64.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $9.02M -$2.59M +$4.42M +63.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $4.6M -$804K +$6.12M +88.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$1.52M $20.5M +$7.51M +57.6% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-23
Q3 2014 -$9.03M -$8.13M -$2.61M -47.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$6.42M -$7.01M -$2.01M -40.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$4.4M -$6.92M -$3.45M -99.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$953K $13M Oct 1, 2013 Dec 31, 2013 8-K/A 2016-06-17
Q3 2013 -$5.52M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$4.99M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$3.47M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.